Sandra Ruiz-Osuna
Overview
Explore the profile of Sandra Ruiz-Osuna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Busquets J, Secanella L, Carnaval T, Sorribas M, Serrano-Navidad M, Alba E, et al.
Cir Esp (Engl Ed)
. 2024 Sep;
102(12):633-641.
PMID: 39304131
Introduction: Embolization could increase the resectability of pancreatic tumors by supercharging visceral arterial perfusion prior to pancreatic surgery with arterial en-bloc resection. Its indications, however, are controversial. Methods: We retrospectively...
2.
Gornals J, Velasquez-Rodriguez J, Bas-Cutrina F, Garcia Garcia de Paredes A, Esteban J, Teran A, et al.
Surg Endosc
. 2024 Mar;
38(4):2148-2159.
PMID: 38448625
Background: Lumen-apposing metal stents (LAMS) have displaced double-pigtail plastic stents (DPS) as the standard treatment for walled-off necrosis (WON),β but evidence for exclusively using LAMS is limited. We aimed to...
3.
Secanella L, Busquets J, Pelaez N, Sorribas M, Laquente B, Ruiz-Osuna S, et al.
Surg Oncol
. 2023 Dec;
52:102027.
PMID: 38113726
Introduction: Borderline Resectable Pancreatic Ductal Adenocarcinoma (BR-PDAC) benefits from neoadjuvant treatment (NAT) with the intent of surgical salvage in the absence of disease progression during chemotherapy (CT) or chemoradiotherapy (CRT)....
4.
Busquets J, Ramirez-Maldonado E, Serrano T, Pelaez N, Secanella L, Ruiz-Osuna S, et al.
Cir Esp
. 2016 Nov;
94(10):578-587.
PMID: 27863693
Introduction: The treatment of patients with non-functioning pancreatic neuroendocrine tumours (NFPNET) is resection in locally pancreatic disease, or with resectable liver metastases. There is controversy about unresectable liver disease. Methods:...
5.
Fabregat J, Busquets J, Pelaez N, Jorba R, Garcia-Borobia F, Masuet C, et al.
Cir Esp
. 2010 Oct;
88(6):374-82.
PMID: 21030012
Introduction: Surgery is the accepted treatment in adenocarcinoma of the head of the pancreas; however, the long-term survival continues to be low. The aim of this study is to define...